¼¼°èÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Ä¡·áÁ¦º°, Åõ¿© °æ·Îº°, À¯Åë °æ·Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Migraine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutics, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1728083
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,286,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,682,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,175,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 38¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 50¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 4.31%·Î ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀº ÆíµÎÅë ¹ß»ý·ü Áõ°¡, ȯÀÚ ÀÎ½Ä Çâ»ó, ¾à¹° °³¹ßÀÇ ºü¸¥ ÁøÀü µîÀ¸·Î ÀÎÇØ ¾ÈÁ¤ÀûÀ¸·Î È®ÀåµÇ°í ÀÖ½À´Ï´Ù. ÆíµÎÅëÀº ¸¸¼º ½Å°æ°è ÁúȯÀ¸·Î Àü ¼¼°èÀûÀ¸·Î ¸¹Àº Àα¸¸¦ ¿µÇâÀ» ¹ÌÄ¡¸ç È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ °­ÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. Ä®½ÃÅä´Ñ À¯ÀüÀÚ °ü·Ã ÆéŸÀ̵å(CGRP) ¾ïÁ¦Á¦ µî°ú °°Àº Áö¼ÓÀûÀÎ Çõ½ÅÀ» ¹ÙÅÁÀ¸·Î ´õ Ÿ°ÙÆÃµÇ°í ¸ÂÃãÇü Ä¡·á¹ýÀ¸·ÎÀÇ ÀüȯÀÌ ÁøÇà ÁßÀÔ´Ï´Ù. ÆíµÎÅëÀÇ °øÁß º¸°Ç ¹× °æÁ¦Àû ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ °ø°ø ¹× ¹Î°£ ºÎ¹® ¸ðµÎ¿¡¼­ ¿¬±¸ °³¹ß(R&D) ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾à ±â¾÷µéÀÌ Â÷¼¼´ë ¾à¹°°ú »ý¹°ÇÐÀû Á¦Á¦ÀÇ Ãâ½Ã¸¦ ÁýÁßÀûÀ¸·Î ÃßÁøÇÔ¿¡ µû¶ó ½ÃÀåÀº ´õ È¿°úÀûÀÌ°í ¸ÂÃãÇü Ä¡·á Àü·«À¸·Î °è¼Ó ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½Å°ú ÇÔ²² °Ç°­ °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Çâ»ó ¹× Á¢±Ù¼º °³¼±Àº Áö¼Ó °¡´ÉÇÑ ½ÃÀå ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð(2024³â) 38¾ï 9,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð(2030³â) 50¾ï 1,000¸¸ ´Þ·¯
CAGR(2025-2030³â) 4.31%
±Þ¼ºÀå ºÎ¹® ÁøÅëÁ¦
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

ÆíµÎÅëÀÇ ³ôÀº À¯º´·ü

ÁÖ¿ä ½ÃÀå °úÁ¦

ÀǾàǰ °³¹ßÀÇ º¹À⼺

ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¤¹Ð ÀÇÇÐ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÀÓ»ó½ÃÇè ºÐ¼®

Á¦5Àå °í°´ÀÇ ¸ñ¼Ò¸®

Á¦6Àå ¼¼°èÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦7Àå ºÏ¹ÌÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦8Àå À¯·´ÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦10Àå ³²¹ÌÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦12Àå ½ÃÀå ¿ªÇÐ

Á¦13Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦14Àå ¼¼°èÀÇ ÆíµÎÅë Ä¡·áÁ¦ ½ÃÀå : SWOT ºÐ¼®

Á¦15Àå Porter's Five Forces ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

Á¦17Àå Àü·«Àû Á¦¾È

Á¦18Àå ±â¾÷ ¼Ò°³¿Í ¸éÃ¥»çÇ×

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Migraine Therapeutics Market was valued at USD 3.89 Billion in 2024 and is projected to reach USD 5.01 Billion by 2030, growing at a CAGR of 4.31% during the forecast period. This market is expanding steadily due to the rising incidence of migraine, growing patient awareness, and rapid advancements in drug development. Migraine, a chronic neurological condition, affects a significant global population, leading to strong demand for effective treatment options. A notable shift is occurring toward more targeted and individualized therapies, supported by ongoing innovations such as calcitonin gene-related peptide (CGRP) inhibitors and gepants, which are demonstrating promising clinical outcomes. Increased recognition of migraine's public health and economic impacts has also driven investment in R&D by both public and private sectors. With pharmaceutical companies focusing on introducing next-generation drugs and biologics, the market continues to evolve toward more effective and personalized treatment strategies. These innovations, along with greater awareness and improved access to healthcare, are expected to support sustained market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.89 Billion
Market Size 2030USD 5.01 Billion
CAGR 2025-20304.31%
Fastest Growing SegmentPain-Relieving Medications
Largest MarketNorth America

Key Market Drivers

High Prevalence of Migraine

The widespread occurrence of migraine is a key driver fueling the growth of the Migraine Therapeutics Market. Migraine affects individuals of all ages, genders, and demographics, making it a pervasive public health issue. The condition is a leading cause of disability and contributes to significant losses in productivity, impacting both individuals and economies. As per a March 2024 WHO report, around 40% of the global population-approximately 3.1 billion people-suffered from migraines and other headache disorders as of 2021. The condition shows a higher prevalence among women, likely due to hormonal factors. Migraine ranks among the top three neurological disorders from childhood through late adulthood. This widespread burden has led to increased attention from healthcare stakeholders, driving awareness, diagnosis, and treatment. The rising recognition of migraine's impact on quality of life has also encouraged the development and uptake of more effective therapies, including CGRP inhibitors and gepants, further expanding the market.

Key Market Challenges

Drug Development Complexity

Developing effective migraine therapeutics presents significant challenges due to the complex nature of the condition. Migraine manifests with diverse symptoms and triggers, requiring a deep understanding of its neurological basis for effective drug design. Identifying precise molecular targets is difficult, as the underlying mechanisms of migraine are still not fully understood. The clinical trial process for migraine treatments can be lengthy and costly, involving large patient populations and extended follow-up periods. Subjective symptom reporting and placebo responses add further complexity. Regulatory agencies such as the FDA require comprehensive evidence of safety and efficacy, necessitating rigorous testing and data collection. In addition, evolving clinical trial endpoints demand constant adaptation from researchers and sponsors. These challenges, combined with high development costs, can delay innovation and restrict market entry, particularly for smaller firms.

Key Market Trends

Precision Medicine

Precision medicine is emerging as a transformative trend in the Migraine Therapeutics Market, offering more effective and individualized treatment strategies. By utilizing genetic, molecular, and clinical data, precision medicine allows for the customization of therapies based on a patient's unique migraine profile. Advances in genetic testing and biomarker analysis enable pharmaceutical developers and healthcare providers to better identify subgroups of patients who are most likely to benefit from specific treatments. This targeted approach improves treatment outcomes, reduces side effects, and enhances patient satisfaction. For pharmaceutical companies, precision medicine increases the efficiency of drug development and can lead to faster regulatory approvals. It also offers the potential for higher market differentiation and pricing power. As demand grows for more personalized healthcare solutions, the integration of precision medicine into migraine treatment protocols is expected to expand significantly, reshaping the market landscape and improving therapeutic success rates.

Key Market Players

Report Scope:

In this report, the Migraine Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Migraine Therapeutics Market, Therapeutics:

Migraine Therapeutics Market, Route of Administration:

Migraine Therapeutics Market, Distribution Channel:

Migraine Therapeutics Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Migraine Therapeutics Market.

Available Customizations:

Migraine Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Clinical Trial Analysis

5. Voice of Customer

6. Global Migraine Therapeutics Market Outlook

7. North America Migraine Therapeutics Market Outlook

8. Europe Migraine Therapeutics Market Outlook

9. Asia-Pacific Migraine Therapeutics Market Outlook

10. South America Migraine Therapeutics Market Outlook

11. Middle East and Africa Migraine Therapeutics Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Global Migraine Therapeutics Market: SWOT Analysis

15. Porter's Five Forces Analysis

16. Competitive Landscape

17. Strategic Recommendations

18. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â